10x Genomics, Inc. 8-K Report: Key Updates from January 12, 2025

Based on the provided XML section of the financial report, here are the key insights and information extracted:

Entity Information:

Company Name: 10x Genomics, Inc.
CIK (Central Index Key): 0001770787
SEC File Number: 001-39035
EIN (Employer Identification Number): 45-5614458
Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588
Phone Number: 925-401-7300

Filing Details:

Filing Type: 8-K (Current Report)
Filing Date: January 12, 2025
This type of filing is typically used to report major events that shareholders should know about.

Stock Information:

Class of Stock: Class A common stock
Par Value: $0.00001 per share
Trading Symbol: TXG
Exchange: NASDAQ

Reporting Period:

Start Date: January 12, 2025
End Date: January 12, 2025
The reporting period is for a single day, which is typical for an 8-K filing that reports specific events occurring on that date.

XML Metadata:

The report is formatted in XBRL (eXtensible Business Reporting Language), which is designed for the electronic communication of business and financial data.

Summary:

This filing provides essential information about 10x Genomics, Inc., including its identity, stock details, and the nature of the filing (8-K) indicating significant corporate events. The single-day reporting period suggests that the disclosure likely pertains to an event or announcement that occurred on January 12, 2025.